Transkaryotic, Sanofi-Aventis SA deal

SNY granted TKTX rights to clinical trial results from a Phase III trial of Dynepo epoetin delta to treat anemia in cancer patients receiving chemotherapy. Under a March deal, TKTX regained marketing ...